All Posts Tagged With: "GlaxoSmithKline"

post thumbnail

Avandia Provides No Significant Benefit in Reduction of Artery Plaque

According to new research presented yesterday at the American Heart Association’s annual meeting in New Orleans, Avandia does not provide any statistically significant reduction in the buildup of plaque in coronary arteries when compared to an older generic diabetes drug. Continued

post thumbnail

Glaxo Dismisses Avandia Liver Failure Risk

Following a petition filed last week by the consumer advocacy group Public Citizen, which called for an Avandia recall due to a risk of liver failure and other life-threatening injuries, GlaxoSmithKline has issued a statement dismissing the claim that there are liver safety issue caused by side effects of Avandia. Continued

post thumbnail

Avandia Recall Urged by Consumer Group

The consumer advocacy group Public Citizen has filed a petition with the FDA calling for an Avandia recall as a result of a number of serious and potentially life threatening side effects associated with the diabetes drug. Continued

post thumbnail

Australian Alert Issued About Avandia Side Effects

About 40,000 Australians taking the diabetes drug Avandia have been told to urgently consult with the doctor about whether they should continue receiving the drugs. Continued

post thumbnail

Avandia Vision Loss Lawsuit Pending in Canada

A lawsuit is currently pending in Canada against the makers of Avandia, involving a lesser known potential side effect of the diabetes drug, which could cause severe vision loss and eye damage, known as macular edema. Continued

post thumbnail

Avandia Lawsuits

Users of the diabetes drug Avandia face a potential increased risk of serious and potentially fatal injuries. Lawsuits are being investigated throughout the United States for users who suffered a heart attack, stroke, congestive heart failure, bone fractures or death. Continued

post thumbnail

Avandia Wrongful Death Lawsuit Filed in California

A California wrongful death lawsuit has been filed against the makers of Avandia, alleging that the Type 2 diabetes drug caused heart attacks, congestive heart failure, and other cardiovascular injuries which killed seven people. Continued

post thumbnail

Avandia Warning Label Updated To Indicate Blood Sugar Control Benefits

GlaxoSmithKline is updating the prescribing information for Avandia to include clinical findings that users have better glycemic control with the drug than with two other diabetes treatments. However, critics who have voiced safety concerns about Avandia, point out that the better control of blood sugar is not particularly useful, since side effects of the drug could increase the risk of a potentially fatal heart attack. Continued